Mankind Pharma to invest Rs. 150 crore in Paonta Sahib plant.

Mankind Pharma said it has invested Rs. 150 crore in its plant at Paonta Sahib and expects to roll out 35 products by the end of 2016.

'... we are concentrating on the production of nutraceuticals, food supplements and beverages. We have invested Rs 150 crore in our plant in Paonta Sahib and are expecting to launch 35 products by the end 2016,' Mankind Pharma MD Sheetal Arora said in a statement.


With a strategic approach on formulations, the company has been focusing on the manufacturing of nutraceuticals with a growth rate of 35 per cent.

Currently, the company's 80 per cent of niche molecules have been concentrated in the production of nutraceuticals and it has recently introduced 24 products under the segment, as more people are becoming health conscious, Arora added.

ET